Chimeric Therapeutics Limited [ASX:CHM] share price and news 2022

Company Description

Chimeric Therapeutics Limited (CHM) is a biotechnology company developing a breakthrough cancer cell therapy drug which was discovered at the prestigious City of Hope Cancer Centre in Los Angeles, California. CHM is developing ground breaking CAR T cell therapy.

Chimeric Therapeutics Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website:

This a small cap company with market cap of 60 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 2.9 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how chm dividend grows in the recent years.

No data